SCHEMBL2199499

SCHEMBL2199499

COc1ccc(C(=O)NCC(N)=O)cc1C(=O)c1ccc(Nc2ccc(F)cc2)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
MAPK14 Q16539 4/20 0.48
MAPK13 O15264 3/20 0.48
MAPK12 P53778 3/20 0.48
MAPK11 Q15759 3/20 0.48
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
PYGL P06737 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
HDAC8 Q9BY41 1/20 0.40
LMNA P02545 1/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
GLA P06280 1/20 0.40
EGFR P00533 1/20 0.40
MET P08581 1/20 0.40
PPARG P37231 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2196998 0.91 MAPK13 (0.51) ALDH1A1MAPK14MAPK13MAPK12MAPK11
SCHEMBL2198975 0.90 MAPK14 (0.50) ALDH1A1MAPK14MAPK13MAPK12MAPK11
SCHEMBL2198442 0.88 MAPK13 (0.46) ALDH1A1MAPK14MAPK13MAPK12MAPK11
SCHEMBL2197745 0.88 MAPK13 (0.46) ALDH1A1MAPK14MAPK13MAPK12MAPK11
SCHEMBL6080531 0.88 MAPK13 (0.46) ALDH1A1MAPK14MAPK13MAPK12MAPK11
SCHEMBL2200691 0.87 MAPK13 (0.46) ALDH1A1MAPK14MAPK13MAPK12MAPK11
SCHEMBL2198174 0.84 MAPK14 (0.43) ALDH1A1MAPK14MAPK13MAPK12MAPK11
SCHEMBL2200514 0.84 MAPK14 (0.52) ALDH1A1MAPK14MAPK13MAPK12MAPK11
SCHEMBL2199856 0.84 MAPK14 (0.52) ALDH1A1MAPK14MAPK13MAPK12MAPK11
SCHEMBL2200130 0.84 MAPK14 (0.52) ALDH1A1MAPK14MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US claimed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 ALDH1A1 88/4885MAPK14 697/4885MAPK13 1063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.